
Torrent Pharmaceuticals (TORNTPHARM) Share Price Rises 2.52% Today
Updated: 22 Oct 2026 • 11:24 am
Posted by:

Torrent Pharmaceuticals Share Price is trading at Rs 4,641.45 today, up 2.52% from the previous close of Rs 4,527.55, while market capitalisation stands at Rs 1,73,078.79 Cr. The move places Torrent Pharmaceuticals Share Price in focus among healthcare names in the Indian stock market, with the current session showing a firm opening and a higher intraday range. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Torrent Pharmaceuticals Share Price today, the key point is the verified price action itself, along with valuation and sector context that can help frame how the stock is positioned against listed peers. Investors watching Torrent Pharmaceuticals Share Price can also monitor whether the current trade remains near the day high and how the valuation compares with the broader Pharmaceuticals & Drugs universe on Univest.
Torrent Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,641.45 |
| Previous Close | Rs 4,527.55 |
| Today's Move | Rs 113.9 (+2.52%) |
| Open | Rs 4,518.05 |
| High | Rs 4,641.45 |
| Low | Rs 4,510.05 |
| Market Capitalisation | Rs 1,73,078.79 crore |
| Market Cap Category | Large Cap |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) rose to Rs 4,641.45 from the previous close of Rs 4,527.55, a move of Rs 113.9 or 2.52%. The stock opened at Rs 4,518.05, reached a high of Rs 4,641.45, recorded a low of Rs 4,510.05.
Torrent Pharmaceuticals Share Price today shows a clean intraday gain of Rs 113.90, or 2.52%, with the stock last trading at Rs 4,641.45. That level also matches the day high, which was Rs 4,641.45, while the day low stood at Rs 4,510.05. The stock opened at Rs 4,518.05, compared with the previous close of Rs 4,527.55, and the day’s movement has kept Torrent Pharmaceuticals Share Price near the upper end of its observed range. The current market capitalisation is Rs 1,73,078.79 Cr. For anyone scanning Torrent Pharmaceuticals Share Price live, this is a straightforward share price rise rather than a story built on an unverified trigger. The next section of Torrent Pharmaceuticals Share Price analysis turns to fundamentals and whether the numbers justify the current attention.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,73,078.79 crore |
| P/E Ratio | 78.96x |
| P/B Ratio | 19.19x |
| ROE | 26.76% |
| ROCE | 19.27% |
| EPS | Rs 57.34 |
| Book Value Per Share | Rs 235.97 |
| Dividend Yield | 0.84% |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) fundamental metrics show P/E 78.96x, P/B 19.19x, ROE 26.76%, ROCE 19.27%. These figures provide context only and are not a buy or sell signal.
Torrent Pharmaceuticals Ltd. has a market capitalisation of Rs 1,73,078.79 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 78.96x, P/B at 19.19x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 26.76% and ROCE of 19.27%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 57.34, book value per share of Rs 235.97, dividend yield of 0.84%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 78.96x |
| Benchmark Median P/E | 31.23x |
| Benchmark Average P/E | 45.39x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 19.19x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 26.76% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 19.27% |
| Benchmark Median ROCE | 13.25% |
| Company Market Capitalisation | Rs 1,73,078.79 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a P/E ratio of 78.96x, which is above the benchmark median of 31.23x, a difference of +152.83%. On its own, the P/E gap is a valuation reference point, not a trading call.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a ROE of 26.76%, which is above the benchmark median of 11.33%, a difference of +136.19%. Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a ROCE of 19.27%, which is above the benchmark median of 13.25%, a difference of +45.43%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,310.94 | 83.04 | 13.75 | 16.19 | 21.51 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,433.99 | 99.43 | 19.28 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,022.18 | 24.7 | 4.13 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,07,527.58 | 31.49 | 3.02 | 11.83 | 16 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a P/E ratio of 78.96x compared with the displayed peer median of 34.61x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 26.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.27% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a market capitalisation of Rs 1,73,078.79 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Torrent Pharmaceuticals
- Torrent Pharmaceuticals Share Price is trading Rs 113.90 higher today, keeping the stock in focus among Stocks in News and Top Gainers Today.
- The current price of Rs 4,641.45 sits at the day high, which makes Torrent Pharmaceuticals Share Price a clear price action watch point.
- Fundamental ratios show a premium valuation, with P/E at 78.96 and P/B at 19.19, while ROE and ROCE remain strong.
- The market cap of Rs 1,73,078.79 Cr places Torrent Pharmaceuticals Share Price well above the industry median company size.
- Sector comparison shows Torrent Pharmaceuticals Share Price trading above benchmark medians on profitability and valuation alike.
About Torrent Pharmaceuticals
Torrent Pharmaceuticals Ltd. operates in Healthcare and is part of the Pharmaceuticals & Drugs industry. The company is known for its pharmaceutical business, and Torrent Pharmaceuticals Share Price reflects the market’s view of that franchise through a large listed valuation. Its latest metrics include market capitalisation, enterprise value context through valuation ratios, profitability measures and per-share fundamentals that investors commonly use in stock analysis. Torrent Pharmaceuticals Share Price also connects with core company financials such as EPS of Rs 57.34 and book value of Rs 235.97, which help frame the accounting base behind each share.
For readers following Torrent Pharmaceuticals Share Price Today, the company’s position in a large industry set and its stronger return ratios are important reference points. Dividend yield is 0.84%, which adds another layer to the company profile even as the main story remains valuation and price action. Torrent Pharmaceuticals Share Price is therefore best viewed as a premium-priced healthcare name with clear benchmarking against a deep peer universe.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Torrent Pharmaceuticals Share Price rising today?
Ans. Torrent Pharmaceuticals Share Price is rising today by 2.52% to Rs 4,641.45. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Torrent Pharmaceuticals Share Price today?
Ans. Torrent Pharmaceuticals Share Price today is Rs 4,641.45. The stock is up Rs 113.90 from the previous close of Rs 4,527.55, with the day high also at Rs 4,641.45.
What is the market capitalisation of Torrent Pharmaceuticals?
Ans. Torrent Pharmaceuticals Share Price is backed by a market capitalisation of Rs 1,73,078.79 Cr. That places the company well above the industry median market cap of Rs 771.43 Cr in its benchmark set.
How does Torrent Pharmaceuticals Share Price compare on valuation?
Ans. Torrent Pharmaceuticals Share Price trades at a P/E of 78.96 and a P/B of 19.19. Both are above the same-industry medians of 31.23 and 2.71, indicating a premium valuation.
Is Torrent Pharmaceuticals Share Price stronger on profitability ratios?
Ans. Torrent Pharmaceuticals Share Price shows ROE of 26.76% and ROCE of 19.27%. Both are above the industry medians of 11.33% and 13.25%, which gives the stock a stronger return profile than the benchmark group.
What do EPS and book value show for Torrent Pharmaceuticals?
Ans. Torrent Pharmaceuticals Share Price is supported by EPS of Rs 57.34 and book value of Rs 235.97. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
Does Torrent Pharmaceuticals offer a dividend yield?
Ans. Torrent Pharmaceuticals Share Price carries a dividend yield of 0.84%. Dividend yield is a historical or current payout measure, so it helps with company comparison but does not guarantee future distributions.
How does Torrent Pharmaceuticals compare with peers?
Ans. Torrent Pharmaceuticals Share Price has a market cap below Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd., but above Laurus Labs Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. on the peer list used here.
Track Torrent Pharmaceuticals Share Price on Univest
Use Torrent Pharmaceuticals Ltd. (TORNTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Torrent Pharmaceuticals Share Price on Univest for live share price updates, valuation ratios, market capitalisation, 52-week levels and broader market insights. Torrent Pharmaceuticals Share Price, Torrent Pharmaceuticals Share Price Today and Torrent Pharmaceuticals Stock News are all available in one place for quick monitoring. Univest also helps readers compare Torrent Pharmaceuticals Share Price with peer companies and industry benchmarks without needing to move between multiple sources.
Recent Articles

RDB Rasayans Ltd. (RDBRL) 52 Week Low Streak: Why It Matters
22 October 2026

Gateway Distriparks Ltd. (GATEWAY) Distriparks 52 Week Low Streak: What It Means Now
22 October 2026

KV Toys India (KVTOYS) Share Price Falls 9.02% in Latest Session
22 October 2026

Algoquant Fintech Ltd. (ALGOQUANT) 52 Week High Streak Extends to Second Straight Session
22 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
RDB Rasayans Ltd. (RDBRL) 52 Week Low Streak: Why It Matters
Gateway Distriparks Ltd. (GATEWAY) Distriparks 52 Week Low Streak: What It Means Now
KV Toys India (KVTOYS) Share Price Falls 9.02% in Latest Session
Algoquant Fintech Ltd. (ALGOQUANT) 52 Week High Streak Extends to Second Straight Session
Supreme Engineering Ltd. Hits Lower Circuit on NSE, 22 October 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





